Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 03 04:00PM ET
1.92
Dollar change
-0.04
Percentage change
-2.04
%
Index- P/E- EPS (ttm)-2.43 Insider Own27.10% Shs Outstand24.55M Perf Week0.52%
Market Cap47.25M Forward P/E- EPS next Y-0.99 Insider Trans-3.47% Shs Float17.94M Perf Month6.67%
Income-65.44M PEG- EPS next Q-0.46 Inst Own50.28% Short Float2.20% Perf Quarter44.36%
Sales23.82M P/S1.98 EPS this Y17.21% Inst Trans13.57% Short Ratio1.63 Perf Half Y-11.52%
Book/sh3.20 P/B0.60 EPS next Y50.87% ROA-51.76% Short Interest0.39M Perf Year-52.24%
Cash/sh3.19 P/C0.60 EPS next 5Y- ROE-62.26% 52W Range1.21 - 5.70 Perf YTD-4.95%
Dividend Est.- P/FCF- EPS past 5Y11.87% ROI-82.35% 52W High-66.32% Beta0.71
Dividend TTM- Quick Ratio3.92 Sales past 5Y225.26% Gross Margin87.18% 52W Low58.68% ATR (14)0.11
Dividend Ex-Date- Current Ratio4.20 EPS Y/Y TTM0.34% Oper. Margin-296.67% RSI (14)56.80 Volatility6.43% 5.48%
Employees89 Debt/Eq0.09 Sales Y/Y TTM10.57% Profit Margin-274.77% Recom3.00 Target Price1.62
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q19.25% Payout- Rel Volume0.37 Prev Close1.96
Sales Surprise-0.18% EPS Surprise21.74% Sales Q/Q-0.37% EarningsAug 07 BMO Avg Volume242.09K Price1.92
SMA202.40% SMA5014.41% SMA2005.87% Trades Volume90,385 Change-2.04%
Date Action Analyst Rating Change Price Target Change
Aug-27-24Downgrade Piper Sandler Overweight → Neutral $5 → $1.75
Aug-21-24Downgrade TD Cowen Buy → Hold
Aug-21-24Downgrade Jefferies Buy → Hold $11 → $1.50
Dec-15-23Downgrade H.C. Wainwright Buy → Neutral
Jan-11-22Initiated Jefferies Buy $45
Oct-01-21Initiated Cowen Outperform
Sep-14-21Initiated Ladenburg Thalmann Buy $51
Sep-08-21Initiated Piper Sandler Overweight $45
Aug-20-24 05:00PM
Aug-07-24 08:00AM
Jul-31-24 04:05PM
Jul-05-24 01:07PM
May-29-24 04:05PM
05:30PM Loading…
May-23-24 05:30PM
May-09-24 01:52PM
May-08-24 12:53PM
08:00AM
May-01-24 08:01AM
Apr-09-24 08:00AM
Apr-03-24 09:40AM
Mar-18-24 09:40AM
Mar-17-24 08:00AM
Mar-15-24 10:43AM
09:05AM Loading…
Mar-13-24 09:05AM
08:00AM
Mar-06-24 08:00AM
Mar-05-24 04:30PM
Mar-01-24 04:08PM
Feb-26-24 04:05PM
Jan-26-24 04:05PM
Jan-19-24 04:05PM
Dec-15-23 09:14AM
Dec-14-23 04:05PM
Nov-08-23 08:46AM
08:00AM
Nov-06-23 04:05PM
Nov-01-23 04:05PM
Oct-19-23 04:05PM
04:05PM Loading…
Oct-12-23 04:05PM
Oct-05-23 04:05PM
Oct-03-23 04:05PM
Oct-02-23 08:00AM
Sep-20-23 04:30PM
Sep-05-23 08:00AM
Aug-09-23 08:00AM
Aug-02-23 08:00AM
May-25-23 05:30PM
May-23-23 08:00AM
May-10-23 08:00AM
May-03-23 08:00AM
Apr-26-23 04:05PM
Apr-14-23 01:00PM
Apr-06-23 04:30PM
Mar-28-23 08:00AM
Mar-27-23 08:00AM
Mar-26-23 02:00PM
Mar-15-23 08:00AM
Mar-03-23 08:00AM
Feb-22-23 08:00AM
Nov-17-22 08:00AM
Nov-09-22 08:00AM
Nov-08-22 04:00PM
Nov-03-22 08:00AM
Oct-27-22 08:00AM
Oct-12-22 08:01AM
08:00AM
Sep-22-22 04:01PM
Sep-01-22 08:00AM
Aug-10-22 08:00AM
Aug-04-22 06:21AM
Jul-28-22 08:30AM
Jun-23-22 08:00AM
Jun-01-22 08:00AM
May-31-22 08:00AM
May-26-22 05:10PM
May-18-22 07:00AM
May-12-22 08:32AM
07:00AM
May-09-22 08:00AM
May-04-22 08:00AM
Apr-28-22 05:07PM
Apr-18-22 08:00AM
Apr-08-22 01:09PM
Apr-01-22 05:13AM
Mar-31-22 02:45PM
Mar-17-22 07:00AM
Mar-01-22 07:00AM
Feb-25-22 04:41AM
Feb-23-22 07:00AM
Jan-04-22 04:30PM
Dec-28-21 09:38AM
Dec-23-21 12:38PM
Dec-21-21 09:38AM
Dec-16-21 09:38AM
Dec-08-21 09:38AM
Nov-27-21 06:01AM
06:01AM
Nov-23-21 04:22PM
06:00AM
Nov-15-21 08:00AM
Nov-13-21 01:35PM
Nov-10-21 07:00AM
Nov-09-21 08:00AM
Nov-01-21 04:05PM
Oct-25-21 08:00AM
Oct-22-21 08:00AM
Oct-19-21 05:22PM
Oct-06-21 08:00AM
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai in November 2007 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Desai NeilEXECUTIVE CHAIRMANSep 03 '24Sale1.7140,00068,3161,171,543Sep 05 05:55 PM
Desai NeilOfficerSep 03 '24Proposed Sale1.79120,000214,416Sep 03 10:40 AM
Desai NeilEXECUTIVE CHAIRMANAug 02 '24Sale1.4118,93326,7051,217,195Aug 05 06:49 PM
Desai NeilEXECUTIVE CHAIRMANAug 01 '24Sale1.5015,41523,0551,236,128Aug 05 06:49 PM
Desai NeilEXECUTIVE CHAIRMANAug 05 '24Sale1.345,6527,5951,211,543Aug 05 06:49 PM
Desai NeilEXECUTIVE CHAIRMANJul 01 '24Sale1.4531,34845,6051,260,195Jul 02 06:37 PM
Desai NeilEXECUTIVE CHAIRMANJul 02 '24Sale1.348,65211,6121,251,543Jul 02 06:37 PM
Desai NeilEXECUTIVE CHAIRMANJun 03 '24Sale1.8119,77535,7651,311,768Jun 05 04:25 PM
Desai NeilEXECUTIVE CHAIRMANJun 04 '24Sale1.7720,22535,7461,291,543Jun 05 04:25 PM
Desai NeilEXECUTIVE CHAIRMANMay 01 '24Sale1.9340,00077,1841,331,543May 01 08:50 PM
Desai NeilEXECUTIVE CHAIRMANApr 02 '24Sale2.2322,22849,5131,371,543Apr 03 04:49 PM
Desai NeilEXECUTIVE CHAIRMANApr 01 '24Sale2.3117,77241,1011,393,771Apr 03 04:49 PM
Desai NeilEXECUTIVE CHAIRMANMar 01 '24Sale1.9727,03653,2261,426,507Mar 04 07:22 PM
Desai NeilEXECUTIVE CHAIRMANMar 04 '24Sale2.1014,96431,4151,411,543Mar 04 07:22 PM
Desai NeilExecutive ChairmanFeb 01 '24Sale1.7442,00073,2691,453,543Feb 02 05:04 PM
Desai NeilExecutive ChairmanJan 02 '24Sale2.0642,00086,5491,495,543Jan 02 07:48 PM
Desai NeilExecutive ChairmanDec 06 '23Sale4.827,03733,9141,537,543Dec 07 04:04 PM
Desai NeilExecutive ChairmanDec 05 '23Sale5.0215,74078,9411,544,580Dec 05 06:40 PM
Desai NeilExecutive ChairmanDec 04 '23Sale5.1510,87655,9861,560,320Dec 05 06:40 PM
Desai NeilExecutive ChairmanDec 01 '23Sale5.148,34742,8811,571,196Dec 05 06:40 PM
Desai NeilExecutive ChairmanNov 02 '23Sale4.4631,662141,1051,579,543Nov 02 06:45 PM
Desai NeilExecutive ChairmanNov 01 '23Sale4.3210,33844,6451,611,205Nov 02 06:45 PM